Clinical Trial Update: Safety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 safety trial of high-dose oral vitamin D3 with calcium in people with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Vitamin D3 with Calcium (Cholecalciferol with calcium)

Snippet

Sponsor: University of Toronto | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED